Home - sovren.media

  • Login
Pennsylvania University Study Finds MRNA Vaccines Gives 5-10% Of Recipients Severe Adverse Reactions Up Next Pennsylvania University Study Finds MRNA Vaccines Gives 5-10% Of Recipients Severe Adverse Reactions

CDC’s Flimsy Study, Digital DL/Vaccine Card & Italian Dept Of Health Revises COVID Deaths To 3783

1,642 views
11/02/2021
  • 32
  • 4
  • Support
    • Share on Sovren
    • Share on Telegram
    • Share on Facebook
    • Share on Twitter
    • Share on Reddit
    • Copy Link
    • Copy Embed Code
TLAVagabond TLAVagabond Verified User 6K followers
Follow
https://www.thelastamericanvagabond.com/cdcs-flimsy-study-digital-dl-vaccine-card-italian-dept-of-health-revises-covid-deaths-to-3783

You must be logged in to post wall comments. Please Login or Signup (free).

Share
(Click in textarea to copy code) Code copied to clipboard.

Related

Pennsylvania University Study Finds MRNA Vaccines Gives 5-10% Of Recipients Severe Adverse Reactions
Pennsylvania University Study Finds MRNA Vaccines Gives 5-10% Of Recipients Severe Adverse Reactions
TLAVagabond The Last American Vagabond Verified User 15.5K views 05/12/2021
WEF Admits COVID Was Around In Mid-2019 & It's Admitted The Vaccine Will NOT Return Us To Normal
WEF Admits COVID Was Around In Mid-2019 & It's Admitted The Vaccine Will NOT Return Us To Normal
TLAVagabond The Last American Vagabond Verified User 10.2K views 11/18/2020
Pfizer Altered Its Formulation For Kids 5-11
Pfizer Altered Its Formulation For Kids 5-11
TLAVagabond The Last American Vagabond Verified User 5.1K views 10/30/2021

Popular Creators

CHD CHD Verified User 29K followers Follow
TLAVagabond TLAVagabond Verified User 6K followers Follow
JasonBassler Jason Bassler Verified User 807 followers Follow
AndrewNapolitano Judge Andrew Napolitano Verified User 84 followers Follow
SamTripoli Sam Tripoli Verified User 116 followers Follow
  • Creators
  • Become a Creator
  • Resources
  • Press
  • Sponsor
  • Blog
  • Support
  • FAQ
  • Sovren Tokens
  • Token FAQ
  • Contact Us
  • About Us
  • Investors
Home - ise.media
©2023 Isegoria, Inc. All rights reserved.
Terms Privacy

Delete Post

Are you sure you want to delete this comment?

Yes